Processing

Please wait...

Settings

Settings

Goto Application

1. WO2011000992 - N-(1-PHENYL-2-OXO-3-PIPERIDYL)SULPHONAMIDE LIBRARIES FOR THE IDENTIFICATION OF BIOLOGICAL AND PHARMACOLOGICAL ACTIVITY

Publication Number WO/2011/000992
Publication Date 06.01.2011
International Application No. PCT/ES2010/070446
International Filing Date 30.06.2010
IPC
C07D 211/76 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
211Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
04with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
68having one double bond between ring members or between a ring member and a non-ring member
72with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
74Oxygen atoms
76attached in position 2 or 6
C07C 237/04 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
CACYCLIC OR CARBOCYCLIC COMPOUNDS
237Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
02having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
04the carbon skeleton being acyclic and saturated
A61K 31/451 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
435having six-membered rings with one nitrogen as the only ring hetero atom
44Non-condensed pyridines; Hydrogenated derivatives thereof
445Non-condensed piperidines, e.g. piperocaine
451having a carbocyclic ring directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
A61K 31/167 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
16Amides, e.g. hydroxamic acids
165having aromatic rings, e.g. colchicine, atenolol, progabide
167having the nitrogen atom of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
CPC
C07C 271/22
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
CACYCLIC OR CARBOCYCLIC COMPOUNDS
271Derivatives of carbamic acids, i.e. compounds containing any of the groups , the nitrogen atom not being part of nitro or nitroso groups
06Esters of carbamic acids
08having oxygen atoms of carbamate groups bound to acyclic carbon atoms
10with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
22to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
C07C 309/66
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
CACYCLIC OR CARBOCYCLIC COMPOUNDS
309Sulfonic acids; Halides, esters, or anhydrides thereof
63Esters of sulfonic acids
64having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
65of a saturated carbon skeleton
66Methanesulfonates
C07D 207/48
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
207Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
46with hetero atoms directly attached to the ring nitrogen atom
48Sulfur atoms
C07D 211/76
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
211Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
04with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
68having one double bond between ring members or between a ring member and a non-ring member
72with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
74Oxygen atoms
76attached in position 2 or 6
C07D 401/12
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
401Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
02containing two hetero rings
12linked by a chain containing hetero atoms as chain links
C07D 409/12
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
409Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
02containing two hetero rings
12linked by a chain containing hetero atoms as chain links
Applicants
  • INSTITUT UNIV. DE CIÈNCIA I TECNOLOGIA, S.A. [ES]/[ES] (AllExceptUS)
  • CASTELLS BOLIART, Josep [ES]/[ES] (UsOnly)
  • MIGUEL CENTENO, David Enrique [ES]/[ES] (UsOnly)
  • PASCUAL GILABERT, Marta [ES]/[ES] (UsOnly)
Inventors
  • CASTELLS BOLIART, Josep
  • MIGUEL CENTENO, David Enrique
  • PASCUAL GILABERT, Marta
Agents
  • PONTI SALES, Adelaida
Priority Data
P20090155501.07.2009ES
Publication Language Spanish (ES)
Filing Language Spanish (ES)
Designated States
Title
(EN) N-(1-PHENYL-2-OXO-3-PIPERIDYL)SULPHONAMIDE LIBRARIES FOR THE IDENTIFICATION OF BIOLOGICAL AND PHARMACOLOGICAL ACTIVITY
(ES) BIBLIOTECAS DE N-(1-FENIL-2-OXO-3-PIPERIDIL)SULFONAMIDAS PARA LA IDENTIFICACIÓN DE ACTIVIDAD BIOLÓGICA Y FARMACOLÓGICA
(FR) BANQUES DE N-(1-PHÉNYL-2-OXO-3-PIPÉRIDYL)SULFONAMIDES POUR L'IDENTIFICATION D'UNE ACTIVITÉ BIOLOGIQUE ET PHARMACOLOGIQUE
Abstract
(EN)
New compounds are continually being sought for the treatment and prevention of disorders. The invention relates to N-(1-phenyl-2-oxo-3-piperidyl)sulphonamides which can be biologically and pharmacologically traced, in order to be used in the search for, and identification of, new lead compounds that can modulate the functional activity of a biological target.
(ES)
Bibliotecas de N-(1-Fenil-2-oxo-3-piperidil)sulfonamidas para la identificación de actividad biológica y farmacológica. Continuamente se están buscando nuevos compuestos para el tratamiento y prevención de trastornos. La invención está relacionada con bibliotecas de N-(1-Fenil-2-oxo-3-piperidil)sulfonamidas que son útiles para ser rastreadas biológica y farmacológicamente, para contribuir en la búsqueda e identificación de nuevos compuestos cabeza de serie capaces de modular la actividad funcional de una diana biológica.
(FR)
L'invention concerne des banques de N-(1-phényl-2-oxo-3-pipéridyl)sulfonamides pour l'identification d'une activité biologique et pharmacologique. La recherche de nouveaux composés destinés au traitement et à la prévention de troubles fait l'objet d'une recherche continue. L'invention concerne des banques de N-(1-phényl-2-oxo-3-pipéridyl)sulfonamides qui sont utiles pour être tracées biologiquement et pharmacologiquement afin de contribuer à la recherche et à l'identification de nouveaux composés tête de série pouvant moduler l'activité fonctionnelle d'une cible biologique.
Also published as
Latest bibliographic data on file with the International Bureau